QDENGA: India’s first approved dengue vaccine
QDENGA, manufactured by Takeda Biopharmaceuticals, has received market authorization from the Drug Controller General of India, making it the first dengue vaccine approved in the country. The vaccine is designed for individuals aged 4 to 60 and protects against all four dengue serotypes, with two doses administered three months apart. Given India's significant dengue burden, with over 2 lakh cases reported in recent years, this vaccine could play a crucial role in public health.